A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Adult Type 2 Diabetes Mellitus
Clinical trial NCT06778967 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06778967
- Sponsor
- Gan & Lee Pharmaceuticals.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-13
- Primary completion
- 2026-12-11
- Enrollment
- 1100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.